In recent trading session, ProPhase Labs Inc (NASDAQ:PRPH) saw 0.47 million shares changing hands at last check today with its beta currently measuring -0.45. Company’s recent per share price level of $0.35 trading at $0.0 or -0.03% at last check today assigns it a market valuation of $14.50M. That most recent trading price of PRPH’s stock is at a discount of -1154.29% from its 52-week high price of $4.39 and is indicating a premium of 37.14% from its 52-week low price of $0.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 7.47 million shares which gives us an average trading volume of 2.75 million if we extend that period to 3-months.
For ProPhase Labs Inc (PRPH), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.15 in the current quarter.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
Upright in the red during last session for losing -0.03%, in the last five days PRPH remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $0.35 price level, adding 5.41% to its value on the day. ProPhase Labs Inc’s shares saw a change of -91.98% in year-to-date performance and have moved -4.78% in past 5-day. ProPhase Labs Inc (NASDAQ:PRPH) showed a performance of -3.08% in past 30-days. Number of shares sold short was 0.16 million shares which calculate 0.09 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 14 to the stock, which implies a rise of 97.5% to its recent value today. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 14. It follows that stock’s current price would drop -3900.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -3900.0% for stock’s current value.
ProPhase Labs Inc (PRPH) estimates and forecasts
This year revenue growth is estimated to rise 214.08% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 3.55M for the same. And 1 analysts are in estimates of company making revenue of 5.69M in the next quarter. Company posted 2.47M and 3.15M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -57.56% during past 5 years.
ProPhase Labs Inc (NASDAQ:PRPH)’s Major holders
Insiders are in possession of 7.99% of company’s total shares while institution are holding 12.14 percent of that, with stock having share float percentage of 13.20%. Investors also watch the number of corporate investors in a company very closely, which is 12.14% institutions for ProPhase Labs Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at PRPH for having 0.66 million shares of worth $2.74 million. And as of 2024-06-30, it was holding 6.9456 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 0.22 million shares on 2024-06-30. The number of shares represents firm’s hold over 2.3349 of outstanding shares, having a total worth of $0.92 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 404.21 shares of worth $0.14 million or 0.97% of the total outstanding shares. The later fund manager was in possession of 140.56 shares on Apr 30, 2025 , making its stake of worth around $48774.0 in the company or a holder of 0.34% of company’s stock.
